Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
SIGA Technologies is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses (Lassa fever, Junin, Machupo, Guanarito, Sabia, and lymphocytic choriomeningitis), dengue virus, and the filoviruses (Ebola and Marburg). SIGA’s product development programs also emphasize the increasingly serious problem of drug resistant bacteria. ( www.siga.com )
SIGA Technologies , Inc.
420 Lexington Avenue Suite 408
New York, New York 10170
USA
Tel: (212) 672-9100
Fax: (212) 697-3130